eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
1) PHARMACEUTICAL INDUSTRY ANALYSIS 1.1 Industry Background: The total industry can broadly be classified into two categories. Theses are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production
Premium Pharmaceutical industry Pharmacology Patent
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
Summer Internship Project In Depth Fundamental Analysis of Pharmaceutical Industry Submitted in partial fulfillment of PGDM program 2009-11 [pic] Submitted by Vikas Khandelwal 17/058 Company Guide Faculty Guide Name: Mr. Ritesh Purohit Name: Ms. Ruchi Paliwal Assistant Vice President Globe Capital Market Ltd. Apeejay School of Management New Delhi July 2010 ACKNOWLEDGEMENT This project would have been difficult to complete without the invaluable contributions
Premium Stock market Fundamental analysis Technical analysis
Indian Software Industry In 1998-99‚ the software industry in India was worth Rs. 158.9 billion (US$ 3.9 billion). If the value of in-house development‚ which is taking place at many large corporates‚ is added then the figure would touch around Rs. 190 billion (US$ 4.6 billion). This phenomenal growth has not been achieved overnight. The C.A.G.R (Compounded Annual Growth Rate) for the Indian software industry revenues in the last five years has been 56.3 percent. Here the C.A.G.R. for the software
Premium System software Computer software Application software
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug
underdog‚ to one that can truly join the ranks of the fastest growing economies in the region. Bangladesh has three key attractions for global investors and multinationals: a large base of low-cost labour‚ a large domestic market of 150mn people‚ and nearly 3bn people in the Asian region that it has market access to. The aim of this paper is to provide global investors with an outline on the challenges and prospects for the Bangladesh economy as well as investment opportunities. The fact that
Premium Investment
Specify the types of country risks that pharmaceutical firms face in international business. How do the political and legal systems of countries affect the global pharmaceutical industry? The different types of country risks for the pharmaceutical firms are: 1. Pricing: Many Asian and African countries are poor and cannot afford the costly medicines. The Pharmaceutical firms spend vast amounts on R&D in creating and marketing drugs‚ thus charging high prices enables for cost of
Premium Pharmaceutical industry Pharmacology Generic drug
Industry overview Pharmaceutical sector is an important industry of any modern day economic power. Pharmaceutical industry in India has a very humble past. After independence‚ development of pharmaceutical industry was one of the top agenda of government along with steel and manufacturing industry. The market was protected against competition for a long period of time by giving incentives to small firms‚ license-raj etc. Today the Indian pharmaceutical industry is the front-runner science-based
Premium Pharmaceutical industry Generic drug Food and Drug Administration
their long-term survival in the intensively competitive and high-stakes drug industry. Industry Analysis -Porter’s Five Forces The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale‚ product differentiation‚ government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct
Premium Marketing Pharmacology Steel